{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T21:07:28Z","timestamp":1789420048015,"version":"build-2803163510"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","funder":[{"name":"the Research Fund of Anhui Medical University","award":["2021xkj134"],"award-info":[{"award-number":["2021xkj134"]}]},{"name":"the Research Fund of Anhui Institute of translational medicine","award":["2022zhyx-B14"],"award-info":[{"award-number":["2022zhyx-B14"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>To develop and validate a multiparametric magnetic resonance imaging (mpMRI)-based radiomics nomogram to predict hormone receptor (HR) status in HER2-low breast cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A total of 198 HER2-low expression breast cancer patients who underwent mpMRI in The First Affiliated Hospital of Anhui Medical University Hospital from January 2019 to January 2025 were retrospectively analyzed. 69.2% (n=137) of patients were HR-positive, and 30.8% (n=61) were HR-negative. Patients were divided into a training set (n=138) and a testing set (n=60) in a 7:3 ratio. Radiomics features were extracted from T2-weighted imaging (T2WI), diffusion-weighted imaging (DWI), and dynamic contrast-enhanced (DCE) images separately, and the radiomics score (radscore) was calculated. The clinical-radiological model (CM), single radiomics model (RM), and mpMRI RM were constructed, and a nomogram integrating radscore with clinical-radiological characteristics was developed. The predictive performance of the models was evaluated by receiver operating characteristic (ROC) curve analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>The area under the curve (AUC) of mpMRI RM in the training set and the testing set was 0.940 and 0.897, respectively, which were superior to that of single-modality models. The nomogram incorporating radscore and clinical-radiological characteristics, including ADC value, T2SI radio, and enhancement pattern, demonstrated higher AUC in both the training set (AUC=0.957) and testing set (AUC=0.891) than other RMs in predicting HR status of HER2-low expression breast cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>An mpMRI-based nomogram incorporating radscore and clinical-radiological characteristics showed good predictive efficacy for assessing the HR status of HER2-low expression breast cancer.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/rct.0000000000001857","type":"journal-article","created":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T20:00:10Z","timestamp":1773172810000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Radiomics Nomogram Based on Multiparametric MRI for Predicting the Hormone Receptor Status of HER2-Low Expression Breast Cancer"],"prefix":"10.1097","volume":"50","author":[{"given":"Weishu","family":"Hou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongli","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-8722-2188","authenticated-orcid":false,"given":"Yongqiang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,9]]},"reference":[{"key":"R1-20260914","first-page":"355","article-title":"Evolving standards of care and new challenges in the management of HER2-positive breast cancer","volume":"70","author":"Choong","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"R2-20260914","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s13058-021-01492-x","article-title":"Landscape of HER2-low metastatic breast cancer (MBC): results from the Austrian AGMT_MBC-Registry","volume":"23","author":"Gampenrieder","year":"2021","journal-title":"Breast Cancer Res"},{"key":"R3-20260914","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2203690","article-title":"Trastuzumab deruxtecan in previously treated HER2-low advanced breast cancer","volume":"387","author":"Modi","year":"2022","journal-title":"N Engl J Med"},{"key":"R4-20260914","doi-asserted-by":"crossref","first-page":"700","DOI":"10.4143\/crt.2023.1138","article-title":"HER2-low breast cancer: now and in the future","volume":"56","author":"Kang","year":"2024","journal-title":"Cancer Res Treat"},{"key":"R5-20260914","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1186\/s12885-023-11421-0","article-title":"Clinicopathological features and prognosis of patients with HER2-low breast cancer","volume":"23","author":"Yang","year":"2023","journal-title":"BMC Cancer"},{"key":"R6-20260914","doi-asserted-by":"crossref","first-page":"5653","DOI":"10.1245\/s10434-023-13311-y","article-title":"Clinical genetic features and neoadjuvant chemotherapy response in HER2-low breast cancers: a retrospective, multicenter cohort study","volume":"30","author":"Yang","year":"2023","journal-title":"Ann Surg Oncol"},{"key":"R7-20260914","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/S1470-2045(21)00301-6","article-title":"Clinical and molecular characteristics of HER2-low-positive breast cancer: pooled analysis of individual patient data from four prospective, neoadjuvant clinical trials","volume":"22","author":"Denkert","year":"2021","journal-title":"Lancet Oncol"},{"key":"R8-20260914","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.pathol.2023.10.022","article-title":"HER2-low breast cancer and response to neoadjuvant chemotherapy: a population-based cohort study","volume":"56","author":"Baez-Navarro","year":"2024","journal-title":"Pathology"},{"key":"R9-20260914","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/j.acra.2020.05.040","article-title":"Radiomics signatures based on multiparametric MRI for the preoperative prediction of the HER2 status of patients with breast cancer","volume":"28","author":"Zhou","year":"2021","journal-title":"Acad Radiol"},{"key":"R10-20260914","doi-asserted-by":"crossref","first-page":"e222646","DOI":"10.1148\/radiol.222646","article-title":"Multiparametric MRI and radiomics for the prediction of HER2-zero, -low, and -positive breast cancers","volume":"308","author":"Ramtohul","year":"2023","journal-title":"Radiology"},{"key":"R11-20260914","doi-asserted-by":"crossref","first-page":"3538","DOI":"10.1158\/1078-0432.CCR-18-3190","article-title":"Radiomics of multiparametric MRI for pretreatment prediction of pathologic complete response to neoadjuvant chemotherapy in breast cancer: a multicenter study","volume":"25","author":"Liu","year":"2019","journal-title":"Clin Cancer Res"},{"key":"R12-20260914","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s13058-019-1187-z","article-title":"Radiomic signatures with contrast-enhanced magnetic resonance imaging for the assessment of breast cancer receptor status and molecular subtypes: initial results","volume":"21","author":"Leithner","year":"2019","journal-title":"Breast Cancer Res"},{"key":"R13-20260914","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.crad.2023.09.013","article-title":"Multiparametric MRI-based radiomics nomogram for predicting the hormone receptor status of HER2-positive breast cancer","volume":"79","author":"Sang","year":"2024","journal-title":"Clin Radiol"},{"key":"R14-20260914","doi-asserted-by":"crossref","first-page":"eabo4802","DOI":"10.1126\/scitranslmed.abo4802","article-title":"Improving breast cancer diagnostics with deep learning for MRI","volume":"14","author":"Witowski","year":"2022","journal-title":"Sci Transl Med"},{"key":"R15-20260914","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.acra.2022.04.004","article-title":"DCE-MRI radiomics analysis in differentiating luminal A and Luminal B breast cancer molecular subtypes","volume":"30","author":"Lafc\u0131","year":"2023","journal-title":"Acad Radiol"},{"key":"R16-20260914","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s11912-023-01372-x","article-title":"Breast MRI: clinical indications, recommendations, and future applications in breast cancer diagnosis","volume":"25","author":"Wekking","year":"2023","journal-title":"Curr Oncol Rep"},{"key":"R17-20260914","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1007\/s11547-023-01710-w","article-title":"Radiomics and machine learning analysis by computed tomography and magnetic resonance imaging in colorectal liver metastases prognostic assessment","volume":"128","author":"Granata","year":"2023","journal-title":"Radiol Med"},{"key":"R18-20260914","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1016\/j.acra.2025.03.010","article-title":"Multiparametric MRI-based interpretable machine learning radiomics model for distinguishing between luminal and non-luminal tumors in breast cancer: a multicenter study","volume":"32","author":"Zhou","journal-title":"Acad Radiol"},{"key":"R19-20260914","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s12885-020-6523-2","article-title":"Predicting the response to neoadjuvant chemotherapy for breast cancer: wavelet transforming radiomics in MRI","volume":"20","author":"Zhou","year":"2020","journal-title":"BMC Cancer"},{"key":"R20-20260914","doi-asserted-by":"crossref","first-page":"e2329933","DOI":"10.2214\/AJR.23.29933","article-title":"Update on DWI for breast cancer diagnosis and treatment monitoring","volume":"222","author":"Gullo","year":"2024","journal-title":"AJR Am J Roentgenol"},{"key":"R21-20260914","doi-asserted-by":"crossref","first-page":"4816","DOI":"10.21037\/qims-22-1318","article-title":"Dynamic contrast-enhanced magnetic resonance imaging features and apparent diffusion coefficient value of HER2-positive\/HR-negative breast carcinoma","volume":"13","author":"Chen","year":"2023","journal-title":"Quant Imaging Med Surg"},{"issue":"suppl 1","key":"R22-20260914","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.1016\/j.acra.2021.07.017","article-title":"Magnetic resonance imaging phenotypes of breast cancer molecular subtypes: a systematic review","volume":"29","author":"Ab Mumin","year":"2022","journal-title":"Acad Radiol"},{"key":"R23-20260914","doi-asserted-by":"crossref","first-page":"95","DOI":"10.21037\/qims-21-355","article-title":"Diffusion-weighted imaging of breast invasive lobular carcinoma: comparison with invasive carcinoma of no special type using a histogram analysis","volume":"12","author":"Jeong","year":"2022","journal-title":"Quant Imaging Med Surg"},{"key":"R24-20260914","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1002\/jmri.21330","article-title":"Estrogen receptor and breast MR imaging features: a correlation study","volume":"27","author":"Chen","year":"2008","journal-title":"J Magn Reson Imaging"},{"key":"R25-20260914","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/j.1524-4741.2010.00982.x","article-title":"The necrosis sign in magnetic resonance-mammography: diagnostic accuracy in 1,084 histologically verified breast lesions","volume":"16","author":"Dietzel","year":"2010","journal-title":"Breast J"},{"key":"R26-20260914","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ejca.2022.07.001","article-title":"HER2-low inflammatory breast cancer: clinicopathologic features and prognostic implications","volume":"174","author":"Tarantino","year":"2022","journal-title":"Eur J Cancer"},{"key":"R27-20260914","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.breast.2022.12.006","article-title":"Comparison of clinicopathological characteristics and response to neoadjuvant chemotherapy between HER2-low and HER2-zero breast cancer","volume":"67","author":"Zhou","year":"2023","journal-title":"Breast"},{"key":"R28-20260914","doi-asserted-by":"crossref","first-page":"e2330280","DOI":"10.2214\/AJR.23.30280","article-title":"High peritumoral and intratumoral T2 signal intensity in HER2-positive breast cancers on preneoadjuvant breast MRI: assessment of associations with histopathologic characteristics","volume":"222","author":"Jirarayapong","year":"2024","journal-title":"Am J Roentgenol"},{"key":"R29-20260914","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1007\/s12282-020-01105-z","article-title":"The association between MRI findings and breast cancer subtypes: focused on the combination patterns on diffusion-weighted and T2-weighted images","volume":"27","author":"Yuen","year":"2020","journal-title":"Breast Cancer"},{"key":"R30-20260914","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s12943-019-1089-9","article-title":"Role of hypoxia in cancer therapy by regulating the tumor microenvironment","volume":"18","author":"Jing","year":"2019","journal-title":"Mol Cancer"}],"container-title":["Journal of Computer Assisted Tomography"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/RCT.0000000000001857","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T21:00:22Z","timestamp":1789419622000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/RCT.0000000000001857"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,11]]},"references-count":30,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/rct.0000000000001857","relation":{},"ISSN":["1532-3145","0363-8715"],"issn-type":[{"value":"1532-3145","type":"electronic"},{"value":"0363-8715","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3,11]]},"assertion":[{"value":"2025-06-09","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-06","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}